Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-08-23

FDA Approved: TRINTELLIX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Trintellix (vortioxetine) submitted by Takeda Pharmaceuticals America, Inc., which appears to involve changes to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRINTELLIX (Vortioxetine)

Snippet

SUPPL AP for TRINTELLIX (VORTIOXETINE)